Get Healthy!

Women may soon have a vaccine they can take during a pregnancy to help protect their newborn from respiratory syncytial virus (RSV).

Following approval one month ago by the U.S. Food and Drug Administration, the Centers for Disease Control and Prevention on Friday also approved the shot, called Abrysvo. That marks the last hurdle needed for the vaccine to become widely available.

�...

Americans seeking out the new COVID boosters are finding themselves held back by insurance entanglements and supply delays.

Some insurers have balked at covering the vaccines, with people arriving at shot appointments only to be told that they’ll have to pay $100 or more out of pocket for the jab.

And in other places, booster appointments simply aren’t available due to supply s...

Symptoms of mild COVID-19 infection have shifted this season, and now are more akin to those of allergies and the common cold, doctors say.

Many people with COVID-19 now are presenting with upper respiratory symptoms like runny nose, watery eyes and a sore throat, said Dr. ...

FRIDAY, Sept. 15, 2023 (HealthDay News) – Kids are back in school and it’s time to think about viruses, for both yourself and them.

It could be an early flu season in the United States, if what happened in the Southern Hemisphere offers any insight, according to Cedars-Sinai in Los Angeles.

The flu vaccine is now available in some locations. A new COVID-19 boost...

An oral vaccine for COVID-19 appears to produce the sort of immune response that could quickly stamp out a developing infection, according to results from a small-scale primate study.

Some monkeys given an experimental COVID vaccine tablet under their tongue developed the type of antibodies that might block the coronavirus as it attempts to infect the body through the mucous membranes of ...

Following on an approval granted Monday by the U.S. Food and Drug Administration, an expert panel from the U.S. Centers for Disease Control and Prevention on Tuesday also signed off on new COVID boosters for Americans.

Final approval is expected from CDC Director Dr. Mandy Cohen, which would set the stage for the updated vaccines to soon become available.

The COVID-19 shots from Pf...

The U.S. Food and Drug Administration on Monday gave the green light to new COVID boosters for Americans, setting the stage for the updated vaccines to become available within days.

The COVID-19 shots from Pfizer and Moderna will join the flu shot and newly approved RSV shots as part of a three-pronged public health strategy to tame the spread of all three viruses this coming winter. The ...

MONDAY, Sept. 11, 2023 (HealthDay News) – In a finding that should ease the minds of Americans ahead of another flu season, this year's vaccines have already cut the risk of hospitalization in half during the South American winter, health officials report.

Even better, the flu virus strains that have been detected in the United States have so far shown a similar pattern to those in Sout...

Some people mistrust the safety and effectiveness of human vaccines for COVID-19 and other diseases, a fact that became abundantly clear during the pandemic.

Now, a new survey of 2,200 dog owners shows this mistrust may often extend to canine vaccinations.

The finding suggests there is spillover between the issues, with those who have negative feelings about human vaccines more lik...

New COVID-19 booster shots could soon pass the needed hurdles for vaccinations to begin next week.

Sources familiar with U.S. Food and Drug Administration plans say boosters could be approved as soon as Friday, NBC News reported.

The U.S. Centers for Disease Control and Prevention Advisory Committee on Immunization Practices is scheduled to meet on Tuesday. CDC director

Respiratory syncytial virus (RSV) is a common viral infection that affects people of all ages, with infants and older adults being particularly vulnerable to severe complications.

Preventing the spread of RSV requires a multi-pronged approach that includes vaccination, good hygiene practices and public health initiatives.

You may have seen recent reports about newly approved vacci...

While it doesn't prevent infection altogether, new research shows the mpox vaccine does reduces the severity of disease in those who fall ill from the virus.

An international team of scientists found that those people who had either mpox vaccination or a previous infection in 2022 had less severe disease.

The researchers studied 38 mpox infections in 37 gay and bisexual men; among ...

Some good news for folks who are worried about the new, troublesome COVID variant known as BA.2.86: Moderna Inc. said Wednesday that its updated vaccine held its own against this highly mutated version of the virus.

While approval for the newest version of the vaccine is still pending from the U.S. Food and Drug Administration, the company offered good reason for why the agency should gi...

A new COVID-19 surge is underway, with seasonal changes and new variants fueling an increase in hospitalizations and deaths.

A new Omicron variant, named Eris, has become dominant in the United States amid signs that an even more highly evolved COVID variant called BA.2.86 is starting to spread across America.

However, experts say the public should react to this latest surge not wit...

New COVID-19 booster shots, reworked to target variants circulating now, could be available by mid-September.

The U.S. Food and Drug Administration is expected to approve them in a few weeks, CNN reported, citing unnamed senior administration officials.

The U.S. Centers for Disease Control and Prevention will soon follow with a safety review and its recommendations. Its Adv...

For the first time in a decade, the rate at which American adolescents received the human papillomavirus (HPV) vaccine has not increased, new data show.

Current guidelines from the U.S. Centers for Disease Control and Prevention recommend that both girls and boys receive t...

Public health officials have detected the new BA.2.86 variant of COVID-19 in U.S. wastewater, giving rise to concerns about the highly mutated variant in the United States.

The U.S. Centers for Disease Control and Prevention announced the detection on Wednesday. ...

Cancer patients with immune systems weakened by treatment are among the groups most concerned about the continued spread of COVID-19 and the chance of the infection becoming severe.

New research suggests more guidance on how often these patients need protective booster shots.

It’s not one-size-fits-all, but depends on the specific treatment, said scientists...

Women may soon have a vaccine they can take during a pregnancy to help protect their newborn from respiratory syncytial virus (RSV), following U.S. Food and Drug Administration approval of the shot, called Abrysvo, on Monday

The vaccine is designed to be given to pregnant women between 32 and 36 weeks of pregnancy as a way to protect infants from birth through 6 months from the sometimes ...

Misinformation about health and medicine is rampant in the United States, with far too many Americans being presented false claims and left wondering what to believe, a new survey reports.

At least 4 in 10 people say they’ve heard 10 specific false claims about COVID-19, reproductive health and gun violence,